Takayo Inoue

发表

A rat retinal damage model predicts for potential clinical visual disturbances induced by Hsp90 inhibitors.

R. Bates, Yuan Liu, Dan Zhou, 2013, Toxicology and applied pharmacology.

Preclinical Development Ganetespib , a Unique Triazolone-Containing Hsp 90 Inhibitor , Exhibits Potent Antitumor Activity and a Superior Safety Pro fi le for Cancer Therapy

D. Proia, K. Foley, R. Blackman, 2012 .

Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy

D. Proia, K. Foley, R. Blackman, 2011, Molecular Cancer Therapeutics.

Immobilization and cleavage of DNA at cationic, self-assembledmonolayers containing C60 on gold

N. Higashi, Takayo Inoue, M. Niwa, 1997 .

Chiral Separation of Fluoxetine and Its Analogs with Charged Cyclodextrins by Capillary Electrophoresis

Takayo Inoue, Jen P. Chang, 2003 .

Phase I Evaluation of STA-1474, a Prodrug of the Novel HSP90 Inhibitor Ganetespib, in Dogs with Spontaneous Cancer

K. Foley, J. Barsoum, J. McCleese, 2011, PloS one.

The HSP90 Inhibitor Ganetespib Alleviates Disease Progression and Augments Intermittent Cyclophosphamide Therapy in the MRL/lpr Mouse Model of Systemic Lupus Erythematosus

R. Bates, J. Chu, Yuan Liu, 2015, PloS one.

A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies

W. Guo, L. Rosen, M. Karol, 2013, BMC Cancer.

HSP90 Inhibitor–SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors

D. Proia, R. Bates, V. Khazak, 2015, Molecular Cancer Therapeutics.

Chiral separation of highly negatively charged enantiomers by capillary electrophoresis.

L. Tillekeratne, Qinfeng Liu, Takayo Inoue, 2004, Journal of chromatography. A.

The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells.

R. Blackman, J. Barsoum, J. Chu, 2012, Free radical biology & medicine.

Abstract C11: The oxidative stress inducer elesclomol requires copper chelation for its anticancer activity

R. Blackman, Suqin He, J. Barsoum, 2009 .

Determination of thiols by capillary electrophoresis with amperometric detection at a coenzyme pyrroloquinoline quinone modified electrode.

Takayo Inoue, J. R. Kirchhoff, 2002, Analytical chemistry.

Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non–Small Cell Lung Cancer

M. Meyerson, Kwok-Kin Wong, G. Shapiro, 2012, Clinical Cancer Research.

FGFR3 Translocations in Bladder Cancer: Differential Sensitivity to HSP90 Inhibition Based on Drug Metabolism

D. Proia, M. Knowles, R. Bates, 2014, Molecular Cancer Research.

Abstract C212: A critical role for the tissue distribution profile in heat shock protein (Hsp) 90 inhibitor-induced ocular toxicity in rats.

Yuan Liu, Dan Zhou, J. Ye, 2011 .

A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies

L. Rosen, M. Karol, J. Goldman, 2013, BMC Cancer.

Capillary Electrophoretic Separation and Quantitation of Ractopamine Stereoisomers Using Cyclodextrins as Chiral Additives

Takayo Inoue, Jen P. Chang, 2003 .

FGFR3 Translocations in Bladder Cancer: Differential Sensitivity to HSP90 Inhibition Based on Drug Metabolism

D. Proia, M. Knowles, R. Bates, 2014, Molecular Cancer Research.

Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non–Small Cell Lung Cancer

M. Meyerson, G. Shapiro, S. Rodig, 2012, Clinical Cancer Research.